New drug tested for severe, sudden hair loss
NCT ID NCT07205159
Summary
This study is testing an investigational drug called FB102 for people with severe to very severe alopecia areata, a condition that causes sudden hair loss. About 32 participants will be randomly assigned to receive either FB102 or a placebo (an inactive substance) to see if the drug is safe and if it helps hair grow back. The main goal is to measure side effects and check for changes in scalp hair coverage after 16 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Auckland
NOT_YET_RECRUITINGAuckland, Auckland, 0632, New Zealand
-
Christchurch
NOT_YET_RECRUITINGChristchurch, Canterbury, 8013, New Zealand
-
Coorparoo
RECRUITINGCoorparoo, Queensland, 4151, Australia
-
Palmerston North
NOT_YET_RECRUITINGPalmerston North, Palmerston North Central, 4414, New Zealand
-
South Yarra
NOT_YET_RECRUITINGSouth Yarra, Victoria, 3141, Australia
-
St Leonards
NOT_YET_RECRUITINGSaint Leonards, New South Wales (nsw), 2065, Australia
Conditions
Explore the condition pages connected to this study.